Information, not a decision
Thyroid cancer: tumour board sheet
Dated public registry data. It contains no treatment recommendation. 12 Nov 2026
Open trials (264)
252 more in the doctor's list on the site.
Phase 3 trials that ended in the last 90 days
No phase 3 trial in this list ended in the last 90 days.
Guidelines
- ESMO Clinical Practice Guidelines
- NCCN Guidelines
- Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers, Part II: Follow-up Surveillance after Initial Treatment 2026.
Links only: read the guideline itself.
Made from the public data of Frontlight Research. Source: ClinicalTrials.gov. 12 Nov 2026
https://frontlightresearch.com/en/doctor/thyroid-cancer/tumor-board